Pacira BioSciences (PCRX) Prepaid Assets (2016 - 2025)
Pacira BioSciences has reported Prepaid Assets over the past 16 years, most recently at $32.6 million for Q4 2025.
- Quarterly results put Prepaid Assets at $32.6 million for Q4 2025, up 48.74% from a year ago — trailing twelve months through Dec 2025 was $32.6 million (up 48.74% YoY), and the annual figure for FY2025 was $32.6 million, up 48.74%.
- Prepaid Assets for Q4 2025 was $32.6 million at Pacira BioSciences, down from $43.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for PCRX hit a ceiling of $43.5 million in Q3 2025 and a floor of $11.3 million in Q3 2021.
- Median Prepaid Assets over the past 5 years was $18.7 million (2023), compared with a mean of $20.8 million.
- Biggest five-year swings in Prepaid Assets: plummeted 32.55% in 2021 and later soared 88.25% in 2025.
- Pacira BioSciences' Prepaid Assets stood at $14.8 million in 2021, then increased by 3.06% to $15.2 million in 2022, then surged by 41.26% to $21.5 million in 2023, then increased by 1.98% to $21.9 million in 2024, then skyrocketed by 48.74% to $32.6 million in 2025.
- The last three reported values for Prepaid Assets were $32.6 million (Q4 2025), $43.5 million (Q3 2025), and $37.2 million (Q2 2025) per Business Quant data.